Beta
97557

Comparative Study between Intranasal Injection of Botulinum Toxin-A and Combined Intranasal Medical Treatment for Allergic Rhinitis

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

Otorhinolaryngology

Abstract

Background: Allergic rhinitis is one of the most common diseases, with no consensus on its ideal treatment. Botulinum Toxin-A was proposed to be an effective treatment
Aim of the work: To estimate the outcome of intranasal injection of Botulinum Toxin-A [BTX-A] as a sole therapy for allergic rhinitis.
Patients and Methods:Ninty patients with classic symptoms of allergic rhinitis were clinically evaluated and asked to complete the score for allergic rhinitis [SFAR] questionnaire using cutoff at >8 as diagnostic AR. Two blood samples [venous] and nasal smears were obtained at the beginning of the study and at the end of 12-weeks after initiation of therapy for estimation of human immunoglobulin E [IgE] and eosinophilia grading. Control group included patients who chose to receive combined medical treatment. BTX-A, 2.5 units were injected intranasally, under 0o rigid telescope guidance. Study outcome was the treatment success rate at the end of 12-w follow-up period.
Results: Intranasal BTX-A injection provided significantly maintained relieve of allergic rhinitis manifestations especially for running nose than combination therapy. The treatment success rate of 1.9 versus 0.7 item/patient in study versus control group with significant difference in favor of BTX-A injection. Serum IgE levels and eosinophilia grades were significantly lower in control patients. Patients' satisfaction grading was significantly more with BTX-A injection.
Conclusion: Intranasal BTX injection could be a safe and effective sole therapeutic modality for patients with long-lasting AR

DOI

10.21608/ijma.2020.26878.1113

Keywords

Allergic Rhinitis, Botulinum toxin-A, Intranasal injection, Medical treatment, Score for allergic rhinitis

Authors

First Name

Nabil

Last Name

Sarhan

MiddleName

-

Affiliation

Department of Otorhinolaryngology, Damietta Faculty of Medicine, Al-Azhar University, Egypt

Email

nabelent@yahoo.com

City

Damietta

Orcid

-

First Name

Mohamed

Last Name

Fathallah

MiddleName

-

Affiliation

Otorhinolaryngology Department, Faculty of Medicine, Al-Azhar University, Egypt.

Email

mnegeib@yahoo.com

City

-

Orcid

-

First Name

Ashraf

Last Name

Wahba

MiddleName

Abdalla

Affiliation

Department of Otorhinolaryngology, Damietta Faculty of Medicine, Al-Azhar University, Egypt.

Email

drashrafwahba70@yahh.com

City

-

Orcid

-

First Name

Ahmed

Last Name

Alwan

MiddleName

-

Affiliation

Department of Clinical Pathology, Damietta Faculty of Medicine, Al-Azhar University, Egypt.

Email

a.raslan78@gmail.com

City

-

Orcid

-

Volume

2

Article Issue

3

Related Issue

16043

Issue Date

2020-07-01

Receive Date

2020-03-29

Publish Date

2020-07-01

Page Start

590

Page End

598

Print ISSN

2636-4174

Online ISSN

2682-3780

Link

https://ijma.journals.ekb.eg/article_97557.html

Detail API

https://ijma.journals.ekb.eg/service?article_code=97557

Order

15

Type

Original Article

Type Code

816

Publication Type

Journal

Publication Title

International Journal of Medical Arts

Publication Link

https://ijma.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023